Holistic health, nutrition, and mental well-being
October 15, 2026 — SYNCHRONIZE-2 studied 752 adults with type 2 diabetes. Survodutide led to 8.2–9.8% weight loss against 3.9% placebo, with high GI-event rates.
October 14, 2026 — What happens when GLP-1 treatment ends? Compare withdrawal trials, exercise follow-up and the limits of evidence about keeping weight off.
August 16, 2026 — Analysis: The appeal is not just that these molecules are new. It is that they seem to offer a precise answer to problems people experience as frustratingly complicated.
August 15, 2026 — A human wound-healing program shows both the promise and the difficulty of translating LL-37 biology into treatment. It also shows why an immune-related mechanism cannot establish an antiviral use.